| ²é¿´: 1021 | »Ø¸´: 9 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û7´Î£¬×÷ÕßsoochowÔö¼Ó½ð±Ò 6.5 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
[×ÊÔ´]
¡¾×ÊÔ´¡¿¾ÛºÏÎïÖÎÁÆ¡¾ Advanced Drug Delivery Reviewsר¼¡¿
|
||
|
Advanced Drug Delivery Reviews ÉÏ×îÐÂÒ»ÆÚ¹ØÓÚ¾ÛºÏÎïÓÃÓÚÖÎÁƵÄר¼£¬Ï£Íû¸ÐÐËȤµÄÅóÓÑϲ»¶¡£ Volume 61, Issue 13, Pages 1117-1232 (12 November 2009) Polymer Therapeutics: Clinical Applications and Challenges for Development Edited by M.J. Vicent and R. Duncan http://www.sciencedirect.com/sci ... 9-999389986-1536091 ¸½ÉÏһƪȫÎÄÏÂÔØ Functional polymers as therapeutic agents: Concept to market place http://www.namipan.com/d/ADDR%202009-61-1121%20Functional%20polymers%20as%20therapeutic%20agents-Concept%20to%20market%20place.pdf/20e03168e4a6ecc1adcdbd5364e68749375a0dfceee00600 Preface 2. Polymer therapeutics: Clinical applications and challenges for development Pages 1117-1120 Mar¨ªa J. Vicent, Helmut Ringsdorf, Ruth Duncan Biologically Active Polymers 3. Functional polymers as therapeutic agents: Concept to market place Pages 1121-1130 Pradeep K. Dhal, Steven C. Polomoscanik, Louis Z. Avila, S. Randall Holmes-Farley, Robert J. Miller Polymer Anticancer Conjugates 4. Development of HPMA copolymer¨Canticancer conjugates: Clinical experience and lessons learnt Pages 1131-1148 Ruth Duncan 5. Clinical experience with anthracycline antibiotics¨CHPMA copolymer¨Chuman immunoglobulin conjugates Pages 1149-1158 nBlanka Rihova 6. Design and development of polymer conjugates as anti-angiogenic agents Pages 1159-1176 Ehud Segal, Ronit Satchi-Fainaro 7. PEG conjugates in clinical development or use as anticancer agents: An overview Pages 1177-1188 Gianfranco Pasut, Francesco M. Veronese 8. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin Pages 1189-1192 Mark E. Davis 9. XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer Pages 1193-1202 Alexander V. Yurkovetskiy, Robert J. Fram 10. Combination therapy: Opportunities and challenges for polymer¨Cdrug conjugates as anticancer nanomedicines Pages 1203-1213 Francesca Greco, Mar¨ªa J. Vicent 11. ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic Pages 1214-1219 David P Nowotnik, Esteban Cvitkovic Key Issues for Transfer from Lab to Clinic 12. Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics Pages 1220-1231 Rog¨¦rio Gaspar, Ruth Duncan |
» ²ÂÄãϲ»¶
´óÁ¬¹¤Òµ´óѧ ÉúÎïÖÊÄÜÔ´Óë²ÄÁÏרҵÕÐÊÕµ÷¼ÁÉú£¬ÓÐÐËȤ¼ÓÁªÏµ£º15732893021
ÒѾÓÐ0È˻ظ´
ѧ¿ÆÉúÎï354Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÉúÎïÁ¦Ñ§Óë×éÖ¯¹¤³ÌѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ257È˻ظ´
´óÁ¬¹¤Òµ´óѧ ÉúÎïÖÊÄÜÔ´Óë²ÄÁÏרҵÕÐÊÕµ÷¼ÁÉú£¬ÓÐÐËȤ¼ÓÁªÏµ£º15732893021
ÒѾÓÐ0È˻ظ´
ÉúÎï¹â×ÓѧÑо¿Ôº/¼¤¹âÉúÃü¿ÆÑ§½ÌÓý²¿ÖصãʵÑéÊÒ Ñо¿Éúµ÷¼Á
ÒѾÓÐ0È˻ظ´
´óÁ¬¹¤Òµ´óѧ ÉúÎïÖÊÄÜÔ´Óë²ÄÁÏרҵÕÐÊÕµ÷¼ÁÉú£¬ÓÐÐËȤ¼ÓÁªÏµ£º15732893021
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á£¡ÉúÎïÓëҽҩר˶
ÒѾÓÐ5È˻ظ´
´óÁ¬¹¤Òµ´óѧ ÉúÎïÖÊÄÜÔ´Óë²ÄÁÏרҵÕÐÊÕµ÷¼ÁÉú£¬ÓÐÐËȤ¼ÓÁªÏµ£º15732893021
ÒѾÓÐ0È˻ظ´
´óÁ¬¹¤Òµ´óѧ ÉúÎïÖÊÄÜÔ´Óë²ÄÁÏרҵÕÐÊÕµ÷¼ÁÉú£¬ÓÐÐËȤ½«¼òÀú·¢Ë͵½507432328@qq.com
ÒѾÓÐ0È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ7È˻ظ´
´óÁ¬¹¤Òµ´óѧ ÉúÎïÖÊÄÜÔ´Óë²ÄÁÏרҵÕÐÊÕµ÷¼ÁÉú£¬ÓÐÐËȤ½«¼òÀú·¢Ë͵½507432328@qq.com
ÒѾÓÐ0È˻ظ´
wgcui
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- BM-EPI: 1
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ¹ó±ö: 0.761
- ½ð±Ò: 5432.6
- Ìû×Ó: 1909
- ÔÚÏß: 367.1Сʱ
- ³æºÅ: 363914
2Â¥2009-10-21 20:07:30
3Â¥2009-10-22 11:02:14
4Â¥2009-10-22 17:15:19
chengcj.2008
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 113 (¸ßÖÐÉú)
- ½ð±Ò: 12446
- Ìû×Ó: 5873
- ÔÚÏß: 581.5Сʱ
- ³æºÅ: 548215
5Â¥2009-10-23 07:39:55
6Â¥2009-10-23 08:16:10
¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö
|
Ó¦ls£¬´«¸öÄÉÃ×ÅÌ~ http://d.namipan.com/d/dae7aad98 ... 9b07c2f58f6519c4800 |
7Â¥2009-10-23 11:58:37
8Â¥2009-10-23 12:07:46
10Â¥2009-10-23 15:02:46
¼òµ¥»Ø¸´
vinci19869Â¥
2009-10-23 12:30
»Ø¸´
лл·ÖÏí£¡














»Ø¸´´ËÂ¥
